Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells

Manon Lernoux(Hôpital Kirchberg), Marc Diederich(Seoul National University)

Clinical Epigenetics

May 19, 2020

10.1186/s13148-020-00839-z

Cited by 55

Related Papers

Anti-inflammatory, pro-apoptotic, and anti-proliferative effects of a methanolic neem (Azadirachta indica) leaf extract are mediated via modulation of the nuclear factor-κB pathway

|Genes & Nutrition|2010|119

Marine Polyether Phycotoxin Palytoxin Induces Apoptotic Cell Death via Mcl-1 and Bcl-2 Downregulation

|Marine Drugs|2023|4